Active yuan Palace ring loved mother of Central and Jeanne ring in the clinical application of the Effects of.docVIP

 PAGE \* MERGEFORMAT 7 Active yuan Palace ring loved mother of Central and Jeanne ring in the clinical application of the Effects of Author: CHEN Yong-feng Aohan Wen Yang Qiujuan [Abstract] Objective: To observe the clinical effect of Cha Jini ring is better than the activity of yuan Palace ring, love the mother ring. Methods: This study selected in May 2003 ~ March 2008 the site voluntarily requested IUD insertion (IUD), good health and no contraindications, Sheung Wan, and were each 300 cases, regular follow-up after IUD insertion (after 1 , 3,6,12 months). Results: The cumulative 12-month pregnancy, the active element 220 with a device Gonghuan 6.7% and loving mother ring of 3%, Jeanne ring was 0.3%; off rate (with Down), the active element 220 with a device for Gonghuan 10%, love mother ring 2%, Jeanne ring was 0.3%; continuation rates, active element 220 with a device Gonghuan 85%, 94% loving mother ring, Jeanne ring is 100%. Conclusion: Jeanne ring with a fall off rate is low and fewer adverse reactions, the cumulative advantage of the high rate of continuation, is worth promoting. [Keywords:] active Yuan Gong ring 220 with a device; loving mother ring; Jeanne ring; contraception Intrauterine device (IUD) is a safe, effective, simple, cheap, reversible, easy to accept the majority of women birth control devices. But its side effects, especially caused by pelvic inflammatory disease, uterine cervix because of bleeding, and too loose, too big and the uterine cavity increased the sensitivity of the uterus, are often easily lead to IUD displacement, even with a device off pregnancy, resulting in falling rates and with devices increased the pregnancy rate. In order to reduce the IUD’s expulsion rate and pregnancy rate with a device to improve continuation rates, I stand in May 2003 since the beginning of the IUD placed on regular follow-up of women (after 1,3,6,12 months) Statistics falling rate, pregnancy rate, adverse reaction rates and continuation ra